2nd Quarter - Amendment

AMERICAN ACADEMY OF NEUROLOGY for AMERICAN ACADEMY OF NEUROLOGY

Firm
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Support for the preservation and expansion of the graduate medical education funding; Support for more research funds for Alzheimers Disease and other dementias including NIH appropriations and private funding models as outlined in HR 1619, the Making Investments Now for Dementia (MIND) Act of 2013; Support for improved concussion safety standards for youth athletics including supporting HR 2118 / S 1014, the Youth Sports Concussion Act of 2013;Support for the expanded and appropriate use of telemedicine; Support S 1027 to improve, coordinate, and enhance rehabilitation research at the NIH; Support the reduction/elimination of specialty tiers within private health plans including supporting HR 460, Patients' Access to Treatments Act of 2013; Support for credential disclosure by health care providers in HR 1427, the Truth in Health Marketing Act of 2013; Opposing automatic sequestration cuts to NIH research; Submitted recommendations to the FDA on the proposed guidance document on Alzheimers disease research; Submitted recommendations to the Assistant Secretary of Planning and Evaluation on what topics should be included in measuring physicians time and work.

LobbyistCovered position, as disclosed
MICHAEL J AMERY —
DEREK CHRISTOPHER BRANDT —
DANEEN P GROOMS —
BRUCE SIGSBEE New —

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA)

Bills named: H.R. 460 (113th), H.R. 1427 (113th), H.R. 2118 (113th), H.R. 1619 (113th)

Medicare/Medicaid MMM

Support permanent repeal and replacement of the Medicare SGR including commenting on House Energy and Commerce/Ways and Means proposals and supporting HR 574 the Medicare Physician Payment Innovation Act of 2013; Support payment reform to more accurately value cognitive care services; Support repeal of the ACAs Independent Payment Advisory Board (H.R. 351/S. 351); Opposing automatic sequestration cuts to Medicare provider payments;Supporting the Enhanced Access to Medicaid Services Act (HR 1838/ S 755) which adds neurology, psychiatry, and Ob/Gyn to the ACA Medicaid at Medicare rates provision; Support for the preservation of the in-office ancillary exception to the stark law; Submitted recommendations to CMS on how to improve health information exchange physicians; Submitted comments to CMS on the Physician Part B filing proposed rule; Submitted comments to CMS in opposition of primary care only E/M codes; Submitted comments to CMS on the 2014 Inpatient Prospective Payment Systems proposed rule; Submitted comments to CMS on how clinical quality measures can be enhanced to better meet physicians needs; Met with CMS to discuss role of AAN in innovative delivery models and preparing our members for the changing healthcare landscape.

LobbyistCovered position, as disclosed
MICHAEL J AMERY —
DEREK CHRISTOPHER BRANDT —
DANEEN P GROOMS —
BRUCE SIGSBEE New —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 1838 (113th), H.R. 351 (113th), H.R. 574 (113th), S. 351 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.